Medical Patent Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Nanotechnology
Research data from the United States, South Korea and Introgen's peptide nanoparticles can include special targeting molecules to further enhance cellular uptake and to improve therapeutic efficacy update nanotechnology knowledge
April 11th, 2007
Investigators in the United States, South Korea and Introgen's peptide nanoparticles can include special targeting molecules to further enhance cellular uptake and to improve therapeutic efficacy have published new nanotechnology data. Study 1: Data detailed in "Fluorocarbon nanoparticles as multifunctional drug delivery vehicles" have been presented. "The history and current status of fluorocarbon nanoparticles in biomedicine is briefly reviewed. The deficiencies of current fluorocarbon nanoparticle formulations are highlighted," researchers in the United States report. "Strategies to remedy such deficiencies and to functionalize fluorocarbon...
Source: Medical Patent Law Weekly (2007-04-11)
|
